Vantage Investment Advisors’s Novo Nordisk NVO Stock Holding History

Vantage Investment Advisors’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$1K	Hold	52	–	–	﹤0.01%	732
2018 Q2	$1K	Hold	52	–	–	﹤0.01%	731
2018 Q1	$1K	Hold	52	–	–	﹤0.01%	777
2017 Q4	$1K	Sell	52 -422	-89%	-$10.7K	﹤0.01%	796
2017 Q3	$11K	Hold	474	–	–	﹤0.01%	547
2017 Q2	$10K	Hold	474	–	–	﹤0.01%	546
2017 Q1	$8K	Sell	474 -3,760	-89%	-$65.5K	﹤0.01%	574
2016 Q4	$76K	Hold	4,234	–	–	0.03%	196
2016 Q3	$88K	Buy	4,234 +622	+17%	+$15.4K	0.04%	177
2016 Q2	$97K	Buy	3,612 +52	+1%	+$1.43K	0.04%	179
2016 Q1	$96K	Hold	3,560	–	–	0.04%	172
2015 Q4	$103K	Sell	3,560 -3,558	-50%	-$98.5K	0.05%	158
2015 Q3	$193K	Hold	7,118	–	–	0.11%	115
2015 Q2	$195K	Hold	7,118	–	–	0.11%	115
2015 Q1	$190K	Buy	7,118 +418	+6%	+$9.63K	0.05%	167
2014 Q4	$142K	Hold	6,700	–	–	0.08%	128
2014 Q3	$160K	Hold	6,700	–	–	0.1%	119
2014 Q2	$155K	Hold	6,700	–	–	0.09%	126
2014 Q1	$153K	Hold	6,700	–	–	0.1%	120
2013 Q4	$124K	Buy	+6,700	New	+$117K	0.08%	131

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Vantage Investment Advisors's NVO Position: Q3 2018 in Review

Vantage Investment Advisors held its Novo Nordisk (NVO) position steady in Q3 2018 at 52 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #732.

Vantage Investment Advisors first reported a position in NVO in Q4 2013 and has held it in 20 quarters since. The position peaked at $195K in Q2 2015. 557 funds tracked by Wall St. Rank hold NVO as of Q3 2018.

Vantage Investment Advisors held 52 shares of Novo Nordisk worth $1K as of Q3 2018.
Vantage Investment Advisors left its Novo Nordisk share count unchanged in Q3 2018.
Novo Nordisk made up ﹤0.01% of Vantage Investment Advisors's portfolio in Q3 2018, its #732 holding.
Vantage Investment Advisors first reported a position in Novo Nordisk in Q4 2013 and has held it in 20 quarters since.
Vantage Investment Advisors's Novo Nordisk position peaked at $195K in Q2 2015.
557 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2018.

Based on Vantage Investment Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.